Ryman Healthcare Ltd Financials

Market Capitalization €1.66 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	9.35
Forward PE
Price to Sales TTM	€2.42
Price to Book MRQ	€0.36
Enterprise to Revenue	6.42
Enterprise to EBITDA	278.76

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-03-31
Profit Margin	0.69%
Operating Margin	-2.94%
Return on Assets TTM	-0.04%
Return on Equity TTM	0.11%

Income Statement

Revenue TTM	€373,994,831
Revenue per Share TTM	€1.00
Quarterly Revenue Growth	18.90%
Gross Profit TTM	€19,406,326
EBITDA	€192,843,000
Net Income to Common TTM	€2,597,337
Diluted EPS TTM	€-0.07
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	€28,361,292
Total Cash per Share MRQ	€0.08
Total Debt MRQ	€
Total Debt to Equity MRQ	58.28
Current Ratio MRQ	0.14
Book Value per Share MRQ	€6.45

Cash Flow

Operating Cash Flow TTM	€358,177,989
Levered Free Cash Flow TTM	€159,636,581

RH7 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	687,641,984
Float Shares	651,472,459
Avg 10 Volume	6,946
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	13.40%
% Held by Institutions	33.75%

Stock Price Summary

Beta	0.75
Fifty Two Week Low	€1.88
Fifty Two Week High	€3.27
Fifty Two Week Change	-37.16%
Day 50 MA	€2.46
Day 200 MA	€2.41

Dividends and Splits

Forward Annual Dividend Rate	€0.17
Forward Annual Dividend Yield	7.16%
Trailing Annual Dividend Rate	€0.21
Trailing Annual Dividend Yield	9.11%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2022-12-08
Last Split Factor
Last Split Date